Moreover, severe COVID-19 patients had less expanded bronchoalveolar CD8+ T cells [27]; reduction and functional exhaustion of T cells were also observed in COVID-19 patients with high levels of the immune-exhaustion marker programmed cell death-1 (PD-1) in peripheral blood T cells [28]. This evidence concerns the gene PDCD1 and COVID-19.